Iman El‐Hariry
Erytech Pharma (France)(FR)NKT Therapeutics (United States)(US)
Publications by Year
Research Areas
Heat shock proteins research, Lung Cancer Treatments and Mutations, ATP Synthase and ATPases Research, Biochemical and Molecular Research, RNA modifications and cancer
Most-Cited Works
- → Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region(2012)860 cited
- → Weekly Volume and Dosimetric Changes During Chemoradiotherapy With Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Observational Study(2010)237 cited
- → A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer(2013)213 cited
- → A single‐arm, multicenter, open‐label phase 2 study of lapatinib as the second‐line treatment of patients with locally advanced or metastatic transitional cell carcinoma(2009)213 cited
- → Targeted Inhibition of the Molecular Chaperone Hsp90 Overcomes ALK Inhibitor Resistance in Non–Small Cell Lung Cancer(2013)209 cited
- Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps.(1997)
- Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor.